Emi Noguchi
10PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Aug 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai
|Aug 14, 2024
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine.Rui Kitadai, Tatsunori Shimoi, Shu Yazaki
|Jan 19, 2023
Challenges in Expediting the Development of Oncology Drugs.Emi Noguchi, Hiroshi Yaginuma, Yasuhiro Fujiwara
|Dec 15, 2022
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer.Shu Yazaki, Roberto Salgado, Tatsunori Shimoi
|Oct 17, 2022
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.Shu Yazaki, Yuki Kojima, Hiroshi Yoshida
|Sep 23, 2021
Critical Appraisal of Adjuvant Platinum-Based Chemotherapy for Basal Subtype Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.Tatsunori Shimoi, Emi Noguchi, Kazuki Sudo
Pageof 2
Frequent Collaborators
6 joint publications
Tatsunori Shimoi
5 joint publications
Yasuhiro Fujiwara
4 joint publications
Kan Yonemori
3 joint publications
Tadaaki Nishikawa
3 joint publications
Yuki Kojima
3 joint publications
Hitomi Sumiyoshi-Okuma
3 joint publications
Kazuki Sudo
2 joint publications
Kenji Tamura
2 joint publications
Shu Yazaki
2 joint publications
Ayumi Saito
